Patent PendingFDA De Novo PathwayBuilt by an SMA Founder
Complex Rehabilitation Technology

Beyond the wheelchair. Beyond every limit.

PathStrider is the world's first intelligent seated robotic independence platform — a single integrated medical device replacing the power wheelchair, the Hoyer lift, the transfer board, the pressure relief cushion, and hours of caregiver assistance every day.

$500K+
5-Yr Cost Replaced
7+1 DOF
Per Robotic Arm
FDA
De Novo Pathway
A seated user navigating rough mountain terrain on the PathStrider quadruped mobility platform
Engineered as a Class II medical device

Daily life for full-time wheelchair users still depends on a fragmented stack of equipment and unpaid labor.

For users with SMA, ALS, spinal cord injury, MS, and other complex conditions, real independence is blocked by gaps the existing market has not addressed. PathStrider closes every one of them in a single device.

Stopped at the Edge

Standard power chairs fail at curbs, gravel, dirt trails, roots, and slopes — excluding users from outdoor life.

Hours of Caregiver Time

Transfers, repositioning, and ROM stretching consume 4–8 hours of paid or family caregiver time daily.

Pressure Injury Risk

Sustained sitting causes pressure sores that lead to hospitalization. Existing cushions are passive and reactive.

The Hoyer Lift

Mechanical patient lifts require a second person, take 10+ minutes per transfer, and strip dignity from a daily routine.

Annotated technical diagram of the PathStrider platform showing wheel-foot lock system, articulated legs, adjustable seat, LiDAR, and joystick control

A single integrated medical device. Seven systems replaced.

Engineered for users who never stand. Powered by NVIDIA Jetson Thor compute, governed by safety-first force limits designed specifically for fragile neuromuscular conditions.

  • Hybrid Wheel-Leg LocomotionWheels for indoors. Locked feet for outdoor terrain. One platform, every surface.
  • 360° Powered Seat with 3-Axis GimbalActive stabilization keeps the seat level on slopes and rough ground.
  • AI Pressure-Mapping Seat64-point sensor array continuously redistributes pressure to prevent injury.
  • 7+1 DOF Therapy-Grade Robotic Arms20 lb payload per arm. Telescoping reach delivers documented PT protocols on demand.
  • Multi-Modal ControlJoystick, voice, EMG, eye-tracking, head array, and BCI-compatible.

Eliminating the Hoyer lift entirely.

A deployable carbon fiber transfer board, coordinated robotic arm stabilization, and AI surface analysis replace the patient lift, the transfer board, and the second person required for every transfer — restoring privacy and independence to the most vulnerable moment of the day.

  • Power CRT Wheelchair$15K – $80K
  • Hoyer Patient Lift$1.5K – $3K
  • Pressure Relief Seating$500 – $3K
  • Home PT — ROM Therapy$150 – $300 / session
  • Personal Care Aide Hours$25 – $40 / hour
5-Year Replaced Cost $500,000+
PathStrider deploying its motorized carbon fiber transfer board to bridge between the seat and a hospital bed for independent transfer

A clear 36–42 month path to FDA clearance and CMS reimbursement.

PathStrider is engineered from day one to meet Complex Rehabilitation Technology coverage criteria. Clinical evidence collection begins during the prototype phase.

PHASE 01

Foundation

2026 – 2027
  • ASU Capstone V1 prototype build
  • 10–15 user clinical pilot study
  • Outcome and usage data collection
  • FDA De Novo classification filing
PHASE 02

Clinical & Regulatory

2027 – 2028
  • Multi-site clinical study (50+ users)
  • FDA De Novo submission
  • HCPCS Level II code application
  • Early payer engagement
PHASE 03

Commercialization

2028 – 2029
  • FDA clearance secured
  • CRT designation & HCPCS code
  • CRT supplier distribution partnerships
  • Initial Medicare coverage decisions

Be among the first considered when PathStrider is available for clinical fitting.

For wheelchair users, families, clinicians, and CRT suppliers. We will reach out when the prototype is ready for trial and when clinical study slots open.

Thank you. Your spot is reserved. We will be in touch.